[Retroperitoneal fibrosis in a patient treated with bromocriptine for a prolactinoma].
We present one case of retroperitoneal fibrosis occurring in a patient presenting with a prolactinoma identified five years previously and treated with bromocriptine since then. Bromocriptine, an ergot derivative with a dopaminergic action, seems to be the cause of the fibrosis in this patient.
Correas Gomez
M
M
Servicio de Urologia, Hospital Marques de Valdecilla, Santander, Cantabria, Espana.
Martin Garcia
B
B
Hernandez Rodriguez
R
R
Portillo Martin
J A
JA
Gutierrez Banos
J L
JL
Masip
T C
TC
Fernandez Gomez
J M
JM
Asensio Lahoz
L A
LA
D001971:Bromocriptine / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D010911:Pituitary Neoplasms / Q000188:drug therapy*; D015175:Prolactinoma / Q000188:drug therapy*; D012185:Retroperitoneal Fibrosis / Q000139:chemically induced* / Q000000981:diagnostic imaging / Q000601:surgery; D014057:Tomography, X-Ray Computed; D014546:Urinary Catheterization
D001971:Bromocriptine
Fibrose rétropéritonéale chez un patient traité par bromocriptine pour un prolactinome.